Man Group plc - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 272 filers reported holding SAGE THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
Man Group plc ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,792,680
-1.1%
80,661
-11.8%
0.01%
-14.3%
Q1 2023$3,835,480
+980.4%
91,408
+909.7%
0.01%
+600.0%
Q3 2022$355,000
-88.9%
9,053
-90.8%
0.00%
-85.7%
Q2 2022$3,189,000
+21.7%
98,727
+24.6%
0.01%
+55.6%
Q1 2022$2,621,000
+1184.8%
79,208
+1620.8%
0.01%
+800.0%
Q3 2021$204,000
+2.0%
4,603
+31.2%
0.00%0.0%
Q2 2021$200,000
-82.4%
3,508
-76.9%
0.00%
-80.0%
Q1 2021$1,139,000
-73.1%
15,218
-68.9%
0.01%
-73.7%
Q4 2020$4,233,000
-46.1%
48,932
-61.9%
0.02%
-38.7%
Q3 2020$7,853,000
+195.6%
128,487
+101.1%
0.03%
+138.5%
Q2 2020$2,657,000
+147.9%
63,893
+71.2%
0.01%
+85.7%
Q1 2020$1,072,000
-53.1%
37,316
+129.2%
0.01%
-12.5%
Q3 2019$2,284,000
+475.3%
16,279
+650.9%
0.01%
+700.0%
Q2 2019$397,000
-81.1%
2,168
-83.6%
0.00%
-87.5%
Q1 2019$2,102,000
-3.7%
13,215
-14.5%
0.01%0.0%
Q3 2018$2,183,000
+202.8%
15,452
+235.6%
0.01%
+166.7%
Q2 2018$721,000
+220.4%
4,604
+229.1%
0.00%
+200.0%
Q1 2018$225,0001,3990.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders